PCC0208009 Enhances the Anti-Tumor Effects of Temozolomide Through Direct Inhibition and Transcriptional Regulation of Indoleamine 2,3-Dioxygenase in Glioma Models
International Journal of Immunopathology and Pharmacology
doi 10.1177/2058738418787991
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
SAGE Publications